Age and quality of in-hospital care of patients with heart failure

European Journal of Public Health

Volumn 14, Issue 2, 2004, Pages 123-127

  Kossovsky, Michel P ^a   Sarasin, François P ^a   Louis Simonet, Martine ^a   Chopard, Pierre ^a   Sigaud, Philippe ^a   Perneger, Thomas V ^a,b   Gaspoz, Jean Michel ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Age; Congestive heart failure; Quality of care

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; GERIATRIC CARE; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT PLANNING;

AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES FOR THE AGED; HEART FAILURE, CONGESTIVE; HOSPITALS, PUBLIC; HOSPITALS, UNIVERSITY; HUMANS; INTERNAL MEDICINE; MALE; MEDICAL AUDIT; MIDDLE AGED; QUALITY OF HEALTH CARE; SWITZERLAND;

EID: 3042595676     PISSN: 11011262     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurpub/14.2.123     Document Type: Article

References (37)

1. Stone PH, Thompson B, Anderson HV, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA 1996;275(14):1104-12.
2. Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction. Ann Intern Med 1996;124(3):283-91.
3. Gurwitz JH, Goldberg RJ. Coronary thrombolysis for the elderly. Is clinical practice really lagging behind evidence of benefit? JAMA 1997;277(21):1723-4.
4. Krumholz HM, Murillo JE, Chen J, et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA 1997;277(21):1683-8.
5. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 1996;156(7):799-805.
6. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997;277(2):115-21.
7. Barakat K, Wilkinson P, Deaner A, Fluck D, Ranjadayalan K, Timmis A. How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet 1999;353(9157):955-9.
8. The Large State Peer Review Organization Consortium. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med 1997;157(10):1103-8.
9. Lye M. Access to advances in cardiology. Lancet 1997;350(9085):1162-3.
10. Kjellstrand CM, Logan GM. Racial, sexual and age inequalities in chronic dialysis. Nephron 1987;45(4):257-63.
11. Kjellstrand CM. Age, sex, and race inequality in renal transplantation. Arch Intern Med 1988;148(6):1305-9.
12. Montague TJ, Ikuta RM, Wong RY, Bay KS, Teo KK, Davies NJ. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989). Am J Cardiol 1991;68(9):843-7.
13. Krumholz HM, Pasternak RC, Weinstein MC, et al. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med 1992;327(1):7-13.
14. Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS. Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med 1992;93(6):605-10.
15. Ashton CM, Kuykendall DH, Johnson ML, et al. A method of developing and weighting explicit process of care criteria for quality assessment. Med Care 1994;32(8):755-70.
16. Kossovsky MP, Sarasin FP, Perneger TV, Chopard P, Sigaud P, Gaspoz J. Unplanned readmissions of patients with congestive heart failure: do they reflect in-hospital quality of care or patient characteristics? Am J Med 2000;109(5):386-90.
17. Pine M, Norusis M, Jones B, Rosenthal GE. Predictions of hospital mortality rates: a comparison of data sources. Ann Intern Med 1997;126(5):347-54.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-83.
19. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Statist Assoc 1979;74:829-36.
20. Clayton D, Hills M. Statistical models in epidemiology. Oxford: Oxford University Press, 1993.
21. Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 1998;352(Suppl. 1):S13-7.
22. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993;14(9):1158-62.
23. Lenfant C. Report of the Task Force on Research in Heart Failure. Circulation 1994;90(3):1118-23.
24. Colucci WS, Packer M, Bristow MR, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 1996;94(11):2800-6.
25. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996;334(21):1349-55.
26. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341(10):709-17.
27. Gambassi G, Lapane KL, Sgadari A, et al. Effects of angiotensin- converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Arch Intern Med 2000;160(1):53-60.
28. Bagg W, Doughty RN, Whalley GA, Gordon G, Sharpe N. Investigation of left ventricular dysfunction in acute dyspnoea: echocardiography is important in the management of heart failure. BMJ 1997;315(7108):604-5.
29. Yu W, Ash AS, Levinsky NG, Moskowitz MA. Intensive care unit use and mortality in the elderly. J Gen Intern Med 2000;15(2):97-102.
30. Smith SC, Jr., Gilpin E, Ahnve S, et al. Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years. J Am Coll Cardiol 1990;16(4):784-92.
31. Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, McNeil BJ. Acute myocardial infarction in the Medicare population: process of care and clinical outcomes. JAMA 1992;268(18):2530-6.
32. Danchin N, Vaur L, Genes N, et al. Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. J Am Coll Cardiol 1997;30(7):1598-605.
33. Rotstein Z, Mandelzweig L, Lavi B, Eldar M, Gottlieb S, Hod H. Does the coronary care unit improve prognosis of patients with acute myocardial infarction? A thrombolytic era study. Eur Heart J 1999;20(11):813-18.
34. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993;32(5):382-7.
35. lezzoni LI, Foley SM, Daley J, Hughes J, Fisher ES, Heeren T. Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA 1992;267(16):2197-203.
36. Hall WD. Representation of blacks, women, and the very elderly (aged > or = 80) in 28 major randomized clinical trials. Ethn Dis 1999;9(3):333-40.
37. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992;268(11):1417-22.